News

All Releases
Tandem Diabetes Care to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
May 09, 2018

SAN DIEGO --(BUSINESS WIRE)--May 9, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the

Tandem Diabetes Care to Present at the Deutsche Bank 43rd Annual Health Care Conference
May 01, 2018

SAN DIEGO --(BUSINESS WIRE)--May 1, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the

Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump
Apr 30, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 30, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps, today announced receipt of CE mark approval for the t:slim X2™ Insulin Pump with Dexcom G5® Mobile continuous glucose monitoring

Tandem Diabetes Care Reports First Quarter 2018 Financial Results
Apr 26, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 26, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended March 31, 2018 .

Tandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New Zealand
Apr 23, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 23, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has entered into distribution agreements with Australasian Medical &

Tandem Diabetes Care Schedules First Quarter 2018 Earnings Press Release and Conference Call
Apr 18, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 18, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its first quarter 2018 results after the financial markets close on Thursday,

Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results
Apr 10, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 10, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported select, unaudited and preliminary results for the quarter ended March 31, 2018 .

Tandem Diabetes Care and Movi SpA Announce Agreement for Distribution of Insulin Pump Products in Italy
Apr 09, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 9, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: tndm), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has entered into a distribution agreement with Movi SpA to commercialize

Tandem Diabetes Care Announces Upcoming Conference Presentations
Mar 07, 2018
SAN DIEGO --(BUSINESS WIRE)--Mar. 7, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the
Tandem Diabetes Care Announces Upcoming Conference Presentations
Mar 07, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the following
Tandem Diabetes Care Announces 2017 Financial Results
Mar 01, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the year and quarter ended December 31, 2017 and financial guidance for
Tandem Diabetes Care Applies for Health Canada Medical Device License
Feb 20, 2018
Commercial launch of the t:slim X2 Insulin Pump in Canada planned for 2H 2018 SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps, today announced its submission of a medical device license
Tandem Diabetes Care and Rubin Medical Announce Agreement for Distribution of Insulin Pump Products in Scandinavia
Feb 15, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has entered into a distribution agreement with Rubin Medical to commercialize Tandem's
Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Care's Pivotal Trial for the t:slim X2 Insulin Pump with Predictive Low Glucose Suspend Feature; Data to be Presented at ATTD 2018 Conference
Feb 15, 2018
VIENNA --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced positive results from a pivotal study of the t:slim X2™ Insulin Pump with Basal-IQ technology, a
Tandem Diabetes Care Schedules Fourth Quarter and Full Year 2017 Earnings Press Release and Conference Call
Feb 14, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its fourth quarter and full year 2017 results after the financial markets close on Thursday,
Tandem Diabetes Care Announces Closing of $69 Million Underwritten Public Offering of Common Stock
Feb 13, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the closing of its previously announced underwritten public offering of 30 million shares of
Tandem Diabetes Care Announces Pricing of $60 Million Underwritten Public Offering of Common Stock
Feb 09, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the pricing of an underwritten public offering of 30 million shares of its common stock at a
Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance
Jan 09, 2018
Guidance for 2018 Reflects Expectation of Continued Growth SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported select, unaudited and preliminary
Tandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study Timeline
Jan 08, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported the successful completion of the first pilot study using a hybrid closed loop system featuring
Tandem Diabetes Care Commences Full Manufacturing Operations at New San Diego Facility
Jan 03, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the commencement of full manufacturing operations at its new facility located on Barnes Canyon
Displaying 1 - 20 of 152